VERTEX PHARMACEUTICALS (U.K.) LIMITED

(Company Number 07643914)

Registered office: 4th Floor, 95 Gresham Street, London, EC2V 7AB

Principal trading address: N/A

Notice is hereby given under Rule 14.28 of the Insolvency (England and Wales) Rules 2016, by Laurence Pagden and Giuseppe Parla of Menzies LLP, 4th Floor, 95 Gresham Street, London, EC2V 7AB, the Joint Liquidators, to the creditors of Vertex Pharmaceuticals (U.K.) Limited, that we intend declaring a first and final dividend to the unsecured creditors of the Company within two months of the last date for proving specified below.

Every person claiming to be a creditor of the Company is required on or before 22 May 2026, which is the last date for proving, to submit a proof of debt to me at Menzies LLP, 4th Floor, 95 Gresham Street, London, EC2V 7AB and, if so requested by me, to provide such further details or produce documentary or other evidence as may appear to be necessary.

A creditor who has not proved his debt before the last date for proving mentioned above is not entitled to disturb, by reason that he has not participated in the dividend, the distribution of that dividend or any other dividend declared before his debt is proved. The winding up of the Company is a members’ voluntary winding up. The distribution proposed to be made is to be the final distribution in the winding up of the above named company and, accordingly, the Joint Liquidators may make the distribution without regard to the claim of any person in respect of a debt not already proved.

Date of Appointment: 15 December 2026

Office Holder Details: Laurence Pagden (IP No. 9055) and Giuseppe Parla (IP No. 24352) both of Menzies LLP, 4th Floor, 95 Gresham Street, London, EC2V 7AB

Further details contact: Laurie'elle Rawlings, Tel: 03309 129563.

Laurence Pagden, Joint Liquidator

10 April 2026

Ag PK11397